A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008)

NCT02987972 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1051

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL: V114 Lot 1
BIOLOGICAL: V114 Lot 2
BIOLOGICAL: Prevnar 13™

Sponsor

Merck Sharp & Dohme LLC